Thank you, Mr. Chair.
Let me be clear that there was no intent to delay the study on vaccines. I think that's an important issue, which I think we all want to make sure we study. We're looking at options on how we might do this. I note that the analysts had indicated that this would be helpful for them. Going back over materials and things we heard a long time ago makes it difficult for us, I think, to capture what we heard in these last number of meetings.
I had in mind that, if need be, I'd be quite willing to participate in additional meetings, as was suggested by Ms. Rempel Garner, during the recess. That was a very welcome suggestion, on my part, so that we could go forward and capture the essence of what we heard. Frankly, I think it's a good idea to do the same thing for vaccines and any of the other programs. I think there's a real benefit for us to do it. If we can find a way to make that happen without delaying our progress on the overall plan, I think we should seriously consider that.
Thank you.